[Association of gastroesophageal reflux and chronic laryngitis].
There is some evidence from anglo-american clinical and experimental studies that gastro-esophageal reflux is more common in patients with laryngitis. Within the framework of an open study, 32 patients with reflux esophagitis and laryngitis were treated with 20 mg omeprazole daily. After 4 weeks at the latest, in all cases inflammation of the esophagus and larynx had healed completely and the patients were without complaints. Suggesting that reflux is the underlying etiology patients with laryngitis seem to benefit from omeprazole.
Jaspersen
D
D
Med. Klinik II, Klinik für Hals-Nasen-Ohren-Krankheiten, Kopf-, Hals- und Plastische Gesichtschirurgie, Städt. Klinikum, Fulda.
Weber
R
R
Hammar
C H
CH
Draf
W
W
D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use; D002908:Chronic Disease; D016145:Endoscopy, Digestive System; D005260:Female; D005764:Gastroesophageal Reflux / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007827:Laryngitis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D009853:Omeprazole